EU regulator approves injectable HIV prevention drug

apnews.com

The European Medicines Agency recommended authorizing a twice-yearly injectable drug to prevent HIV, potentially ending its transmission. The drug, lenacapavir, was found highly effective and of major public health interest. It is already used to treat HIV and studies showed it was nearly 100% effective in preventing transmission. This injectable offers longer protection than existing options, but concerns exist about its widespread availability, though Gilead plans generic versions for many low-income countries.


With a significance score of 6.6, this news ranks in the top 0.1% of today's 25317 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: